Elevated uric acid increases the risk for kidney disease

Journal of the American Society of Nephrology

Volumn 19, Issue 12, 2008, Pages 2407-2413

  Obermayr, Rudolf P ^a   Temml, Christian ^b   Gutjahr, Georg ^c   Knechtelsdorfer, Maarten ^a   Oberbauer, Rainer ^c,d   Klauser Braun, Renate ^a  

^a DANUBE HOSPITAL   (Austria)

^b Gesundheit und Soziales)   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d KH Elisabethinen   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; URIC ACID BLOOD LEVEL;

EID: 57149091788     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2008010080     Document Type: Article

References (50)

1. US Renal Data System: USRDS 2003 Annual Data Report, Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2003
2. Stengel B, Billon S, Van Dijk PC, Jager KJ, Gekker FW, Simpson K, Briggs JD: Trends in the incidence of renal replacement therapy for end stage renal disease in Europe, 1990-1999. Nephrol Dial Transplant 18: 1824-1833, 2003
3. Kramar R, Oberbauer R: Austrian Dialysis and Transplantation Registry (OEDTR)-Annual Report 2007. Austrian Society of Nephrology. Available at: http://www.nephro.at/oedr2006/oedr2006.htm. Accessed June 25, 2008
4. Tomita M, Mizuno S, Yamanaka H, Hosoda Y, Sakuma K, Matuoka Y, Odaka M, Yamaguchi M, Yosida H, Morisawa H, Murayama T: Does hyperuricaemia affect mortality? A prospective cohort study of Japanese male workers. J Epidemiol 10: 403-409, 2000
5. Nagakawa T, Kang DH, Feig D, Sanchez-Lozada LG, Srinivas TR, Sautin Y, Ejaz AA, Segal M, Johnson RJ: Unearthing uric acid: An ancient factor with recently found significance in renal and cardiovascular disease. Kidney Int 69: 1722-1725, 2006
6. Nagahama K, Inoue T, Iseki K, Touma T, Kinjo K, Ohya Y, Takishita S: Hyperuricaemia as a predictor of hypertension in a screened cohort in Okinawa, Japan. Hypertens Res 27: 835-841, 2004
7. Sundstrom J, Sullivan J, D'Agostino RB, Levey D, Kannel WB, Vasan RS: Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension 45: 28-33, 2005
8. Nakagawa T, Mazzali M, Kang DH, Sanchez-Lozada LG, Herrara-Acosta J, Johnson RJ: Uric acid: A uremic toxin? Blood Purif 24: 67-70, 2006
9. Kang DH, Nakagawa T, Feng L, Watanabe S, Han L, Mazzali M, Truong L, Harris R, Johnson RJ: A role of uric acid in the progression of renal disease. J Am Soc Nephrol 13: 2888-2897, 2002
10. Heinig M, Johnson RJ: Role of uric acid in hypertension, renal disease, and metabolic syndrome. Cleve Clin J Med 73: 1059-1064, 2006
11. Fang J, Alderman MH: Serum uric acid and cardiovascular mortality: The NHANES I epidemiologic follow-up study, 1971-1992. JAMA 283: 2404-2410, 2000
12. Johnson RJ, Segal MS, Srinivas T, Ejaz A, Mu W, Roncal C, Sànchez-Lozada LG, Gersch M, Rodriguez-Iturbe B, Kang DH, Acosta JH: Essential hypertension, progressive renal disease, and uric acid: A pathogenetic link? J Am Soc Nephrol 16: 1909-1919, 2005
13. Domrongkitchaiporn S, Sritara P, Kitiyakara C, Stitchantrakul W, Krittaphol V, Lolekha P, Cheepudomwit S, Yipintsoi T: Risk factors for development of decreased kidney function in a Southeast Asian population: A 12-year cohort study. J Am Soc Nephrol 16: 791-799, 2005
14. Obermayr RP, Temml C, Knechtelsdorfer M, Gutjahr G, Kletzmayr J, Heiss S, Ponholzer A, Madersbacher S, Oberbauer R, Klauser-Braun R: Predictors of new-onset decline in kidney function in a general middle-European population. Nephrol Dial Transplant 23: 1265-1273, 2008
15. Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Takishita S: Significance of hyperuricaemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis 44: 642-650, 2004
16. Glinsberg MH, Kozin F, O'Malley M, McCarty DJ: Release of platelet constituents by monosodium urate crystals. J Clin Invest 60: 999-1007, 1997
17. Kang DH, Nakagawa T: Uric acid and chronic renal disease: Possible implication of hyperuricaemia on progression of renal disease. Semin Nephrol 25: 43-49, 2005
18. Kang D-H, Yu ES, Park J-E, Yoon K-I, Kim M-G, Johnson RJ: Uric acid induced C-reactive protein expression via upregulation of angiotensin type 1 receptors in vascular endothelial cells and smooth muscle cells [Abstract]. J Am Soc Nephrol 14: 136A, 2003
19. Sanchez-Lozada LG, Tapia E, Santamaria J, Avila-Casado C, Soto V, Nepomuceno T, Ródriguez-Iturbe B, Johnson RJ, Herrara-Acosta J: Mild hyperuricaemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int 67: 234-247, 2005
20. Johnson RJ, Kang DH, Feig D, Kivlighn S, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrara-Acosta J, Mazzali M: Is there a pathogenic role for uric acid in hypertension, and cardiovascular and renal disease? Hypertension 41: 1183-1190, 2003
21. Szklo M, Nieto FJ, eds.: Epidemiology Beyond the Basics, 2nd Ed., Boston, Jones and Bartlett Publishers, 2007, pp 154-187
22. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis 39[Suppl 1]: S1-S266, 2002
23. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [published erratum appears in JAMA 290: 197, 2003]. The JNC 7 report. JAMA 289: 2560-2571, 2003
24. Sica DA, Schoolwerth AC: Handling of organic anions and cations: Excretion of uric acid. In: The Kidney, 7th Ed., edited by Brenner BM, Philadelphia, WB Saunders, 2004, pp 645-649
25. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470, 1999
26. Lindeman RD, Tobin J, Shock NW: Longitudinal studies on the rate of decline in renal function with aging. J Am Geriatr Soc 33: 278-285, 1985
27. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F, American Heart Association, National Heart, Lung and Blood Institute: Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung and Blood Institute Scientific Statement. Circulation 112: 2735-2752, 2005
28. Choi HK, Ford ES: Prevalence of the metabolic syndrome in individuals with hyperuricaemia. Am J Med 120: 442-447, 2007
29. Tsouli SG, Liberopoulos EN, Mikhailidis DP, Athyros VG, Elisaf MS: Elevated serum uric acid levels in metabolic syndrome: An active component or an innocent bystander? Metabolism 55: 1293-1301, 2006
30. Forman JP, Choi H, Curhan GC: Plasma uric acid level and risk factor for incident hypertension among men. J Am Soc Nephrol 18: 287-292, 2007
31. Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS: Uric acid and incident kidney disease in the community. J Am Soc Nephrol 19: 1204-1211, 2008
32. Siu YP, Leung KT, Tong MK, Kwan TH: Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis 47: 51-59, 2006
33. Kanbay M, Ozkara A, Selcoki Y, Isik B, Turgut F, Bavbek N, Uz E, Akzay A, Yigitoglu R, Covic A: Effect of treatment of hyperuricaemia with allopurinol on blood pressure, creatinine clearance, and proteinuria in patients with normal renal functions. Int Urol Nephrol 39: 1227-1233, 2007
34. Taalat KM, El-Sheikh AR: The effect of mild hyperuricaemia on urinary transforming growth factor beta and the progression of chronic kidney disease. Am J Nephrol 27: 435-440, 2007
35. Iseki K, Oshiro S, Tozawa M, Iseki C, Ikemiya Y, Takishita A: Significance of hyperuricaemia on the early detection of renal failure in a cohort of screened subjects. Hypertens Res 24: 691-697, 2001
36. Viazzi F, Leoncini G, Ratto E, Falqui V, Parodi A, Conti N, Derchi LE, Tomolillo C, Deferrari G, Pontremoli R: Mild hyperuricaemia and subclinical renal damage in untreated primary hypertension. Am J Hypertens 20: 1276-1282, 2007
37. Wang Y, Wang QJ: The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: New challenges of the old problem. Arch Intern Med 164: 2126-2134, 2004
38. Sui X, Church TS, Meriwether RA, Lobelo F, Blair SN: Uric acid and the development of metabolic syndrome in women and men. Metabolism 57: 845-852, 2008
39. Van Biesen W, Vanholder R, Veys N, Verbeke F, Delanghe J, De Bacquer D, Lameire N: The importance of standardization of creatinine in the implementation of guidelines and recommendations for CKD: Implications for CKD management programs. Nephrol Dial Transplant 21: 77-83, 2006
40. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA 298: 2038-2047, 2007
41. Pöllmann G, Kullich W, Klein G: Therapy of hyperuricaemia and gout. Wien Med Wochenschr 147: 382-387, 1997
42. Stevens LA, Coresh J, Greene T, Levey AS: Assessing kidney function: Measured and estimated glomerular filtration rate. N Engl J Med 354: 2473-2483, 2006
43. Coresh J, Stevens LA: Kidney function estimation equations: Where do we stand? Curr Opin Nephrol Hypertens 15: 276-284, 2006
44. Hallan S, Asberg A, Lindberg M, Johnsen H: Validation of the Modification of Diet in Renal Disease formula for estimating GFR with special emphasis on calibration of the serum creatinine assay. Am J Kidney Dis 44: 84-93, 2004
45. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P, Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26: 3160-3167, 2003
46. Wolfinger R, O'Connell M: Generalized linear mixed models: A pseudo-likelihood approach. J Stat Comput Simul 48: 233-243, 1993
47. Chambers J, Hastie T: Statistical Models in S. London, United Kingdom: Chapman & Hall, 1991, pp 32-37
48. R Development Core Team: R: A Language Environment for Statistical Computing. Vienna, R Foundation for Statistical Computing, 2007. Available at: http://www.R-project.org. Accessed April 25, 2008
49. Bates D: Fitting linear mixed models in R. R-News 5: 27-30, 2005
50. Soo Y-W, Douglas M: Multiresponse spline regression. Computational Statistics & Data Analysis 22: 619-631, 1996